FEXINIDAZOLE
| Brand name | FEXINIDAZOLE |
|---|---|
| Active ingredient | FEXINIDAZOLE |
| Strength | 600MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | July 2021 |
| Marketing status | RX |
| Code | Expires |
|---|---|
| ODE-359 | July 2028 |
| NCE | July 2026 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.